Stephen McMorn

782 total citations
17 papers, 603 citations indexed

About

Stephen McMorn is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Stephen McMorn has authored 17 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Stephen McMorn's work include Ion channel regulation and function (5 papers), Diabetes Treatment and Management (5 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Stephen McMorn is often cited by papers focused on Ion channel regulation and function (5 papers), Diabetes Treatment and Management (5 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Stephen McMorn collaborates with scholars based in United Kingdom, United States and Spain. Stephen McMorn's co-authors include Mark R. Boyett, Andrew Zambanini, Jeremy Roberts, Günter A.J. Riegger, John J.V. McMurray, Per Hildebrandt, Henry J. Dargie, John Wilding, Mark Heise and Simon M. Harrison and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and The Journal of Physiology.

In The Last Decade

Stephen McMorn

17 papers receiving 574 citations

Peers

Countries citing papers authored by Stephen McMorn

Since Specialization

Citations

This map shows the geographic impact of Stephen McMorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen McMorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen McMorn more than expected).

Fields of papers citing papers by Stephen McMorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen McMorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen McMorn. The network helps show where Stephen McMorn may publish in the future.

Co-authorship network of co-authors of Stephen McMorn

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen McMorn. A scholar is included among the top collaborators of Stephen McMorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen McMorn. Stephen McMorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study 2025 ·British Journal of Cancer ·Timothy A. Yap, Patricia LoRusso, Rowan Miller, Rebecca Kristeleit, Amanda G. Paulovich, Stephen McMorn, Lenka Oplustil O’Connor, (unknown), Paola Marco‐Casanova, Eric T. Gangl, Bharat Patel, Mark J. O’Connor, Emma Dean, (unknown), Ruth Plummer	2
2	Rationale and design of phase 1 FTIH study of FOXP3 antisense oligonucleotide AZD8701 in patients with selected advanced solid tumors. 2022 ·Journal of Clinical Oncology ·Michele Petruzzelli, Sophie Postel‐Vinay, Elena Garralda, John D. Powderly, Melissa L. Johnson, (unknown), Christos E. Kyriakopoulos, Rafael J. Villanueva, Funda Meric‐Bernstam, Cesar Augusto Santa-Maria, Mateusz Opyrchal, John Stone, Frederick W. Goldberg, Stephen McMorn, (unknown), Alvin Milner, Helen K. Angell, (unknown), Christophe Massard, Lillian L. Siu	1
3	Reduced cognitive and psychomotor impairment with extended-release oxymorphone versus controlled-release oxycodone. 2011 ·PubMed ·Kerri A. Schoedel, Stephen McMorn, Bijan Chakraborty, (unknown), Edward M. Sellers	12
4	Positive and negative subjective effects of extended-release oxymorphone versus controlled-release oxycodone in recreational opioid users 2011 ·Journal of Opioid Management ·Kerri A. Schoedel, Stephen McMorn, (unknown), Susan Potts, (unknown), Edward M. Sellers	23
5	Oral intact extended-release oxymorphone is associated with less liking and lower positive subjective effects than equianalgesic doses of oral intact controlled-release oxycodone in healthy nondependent recreational opioid users 2010 ·Journal of Pain ·Edward M. Sellers, Kerri A. Schoedel, Stephen McMorn, (unknown), Bijan Chakraborty, Susan Potts	3
6	A retrospective evaluation of congestive heart failure and myocardial ischemia events in 14 237 patients with type 2 diabetes mellitus enrolled in 42 short‐term, double‐blind, randomized clinical studies with rosiglitazone 2008 ·Pharmacoepidemiology and Drug Safety ·Alexander R. Cobitz, Andrew Zambanini, Margaret O. Sowell, Mark Heise, (unknown), Stephen McMorn, Marc J. Semigran, Gary G. Koch	34
7	A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in african american and hispanic american patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy 2007 ·Clinical Therapeutics ·J. K. Davidson, Stephen McMorn, Barry D. Waterhouse, Alexander R. Cobitz	19
8	A Randomized, Placebo-Controlled Trial Assessing the Effects of Rosiglitazone on Echocardiographic Function and Cardiac Status in Type 2 Diabetic Patients With New York Heart Association Functional Class I or II Heart Failure 2007 ·Journal of the American College of Cardiology ·Henry J. Dargie, Per Hildebrandt, Günter A.J. Riegger, John J.V. McMurray, Stephen McMorn, Jeremy Roberts, Andrew Zambanini, John Wilding	153
9	Effect of rosiglitazone on factors related to endothelial dysfunction in patients with type 2 diabetes mellitus 2007 ·Atherosclerosis ·Jean‐Paul Albertini, Stephen McMorn, Hongzi Chen, (unknown), P. Valensi	17
10	Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria 2006 ·Journal of Hypertension ·George L. Bakris, Luís M. Ruilope, Stephen McMorn, Wayde M. Weston, Mark Heise, Martin I. Freed, Lisa E. Porter	85
11	Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: A 24-week, multicenter, randomized, double-blind, parallel-group study 2005 ·Clinical Therapeutics ·Clifford J. Bailey, (unknown), (unknown), Stephen McMorn, Jill Donaldson, (unknown), Murray Stewart	63
12	The Role of Na⁺−Ca²⁺ Exchange Current in Electrical Restitution in Ferret Ventricular Cells 1997 ·The Journal of Physiology ·(unknown), Stephen McMorn, Simon M. Harrison, Peter Taggart, Mark R. Boyett	33
13	Comparison of ultra‐slow, voltage‐dependent inactivation of the cardiac L‐type Ca2+ channel with Ca2+ or Ba2+ as the charge carrier in ferret ventricular myocytes 1996 ·Experimental Physiology ·Stephen McMorn, (unknown), (unknown), Mark R. Boyett	4
14	Regional differences in the negative inotropic effect of acetylcholine within the canine ventricle. 1996 ·The Journal of Physiology ·Zhaokang Yang, Mark R. Boyett, (unknown), Stephen McMorn, (unknown), Fazlul Karim	34
15	A list of vertebrate cardiac ionic currents nomenclature, properties, function and cloned equivalents. 1996 ·PubMed ·Mark R. Boyett, (unknown), (unknown), Stephen McMorn, (unknown), (unknown)	25
16	Inhibition of neuronal nicotinic acetylcholine receptors by imipramine and desipramine 1993 ·European Journal of Pharmacology ·(unknown), Stephen McMorn, Helen L. Reeve, Christopher N. Wyatt, Peter F. T. Vaughan, Chris Peers	53
17	A direct negative inotropic effect of acetylcholine on rat ventricular myocytes 1993 ·American Journal of Physiology-Heart and Circulatory Physiology ·Stephen McMorn, Simon M. Harrison, Weijin Zang, Xin Yu, Mark R. Boyett	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact